Mounjaro side effects in the first week: what's normal, what to watch for

Nausea, indigestion, diarrhoea and constipation are the most frequently reported side effects during the first week; they are usually mild to moderate and tend to settle.
The 2.5mg starting dose is designed specifically to reduce early tolerance reactions — the aim is gradual adjustment before any dose increase.
Severe, persistent stomach pain that spreads to your back requires urgent medical attention; the MHRA highlighted acute pancreatitis as a known, infrequent but serious risk for GLP-1 medicines in January 2026.
Any suspected side effect (however minor) can be reported to the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk.

Most people experience some side effects in their first week on Mounjaro, and the majority are gastrointestinal — nausea is the most common, affecting a significant proportion of people starting tirzepatide at 2.5mg. Symptoms typically peak in the first few days after injection and ease as your body adjusts over the following week or two. Mounjaro is a prescription-only medicine, so a qualified prescriber will discuss these effects with you before treatment begins. Knowing what to expect (and what falls outside the normal range) makes those early days considerably easier to navigate.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to make decisions about your first week on Mounjaro, based on what you're feeling

The decision that matters most: 'Is what I'm feeling normal?'

That question sits at the heart of the first week. Tirzepatide works partly by slowing how quickly food leaves your stomach, a mechanism that reduces appetite but also explains why your digestive system can protest in the early days. The NHS patient information for tirzepatide lists nausea, vomiting, diarrhoea, constipation, stomach discomfort, burping and reflux as common reactions. Fatigue and headache appear too, though less consistently.

Most of these settle within a week to a fortnight as your body acclimatises. The starting dose of 2.5mg exists precisely to ease this process, it gives your system time to adjust before the dose is reviewed. Many people find the first two to three days post-injection are the most noticeable, with symptoms fading towards the end of the week.

Injection-site reactions (redness, mild swelling or itching where you inject) are also normal. Rotating sites between your abdomen, thigh and upper arm with each weekly dose helps. If you're unsure what to expect on the day you take your very first dose, the detail on what the first day typically feels like may be useful reading before you inject.

Practical steps that can ease first-week discomfort

Small changes to eating habits make a real difference during this period. Eating slowly, choosing smaller portions and avoiding heavy, fatty meals reduces the likelihood of nausea worsening after you eat. Staying well hydrated matters too, particularly if loose stools or vomiting occur, since dehydration compounds the discomfort and, in more severe cases, can affect your kidneys.

Timing your injection can also help. Some people find injecting in the evening means the peak of any nausea happens overnight rather than disrupting a working day. Others prefer the morning and find the effect manageable. There's no single right answer; it's worth trying the timing that fits your routine and discussing it with your prescriber if you're struggling. A question our prescribers hear fairly often is whether skipping meals helps, it doesn't reliably, and maintaining protein intake is particularly important while on tirzepatide.

If your week-one experience leaves you wondering whether symptoms are improving as expected, the week-two picture gives a useful sense of what progression typically looks like.

When first-week symptoms cross a line that needs medical attention

Most side effects in week one are uncomfortable, not dangerous. The distinction worth holding onto: persistent symptoms that feel disproportionate to the descriptions above, or that are getting worse rather than easing, deserve a call to your prescriber or GP rather than a wait-and-see approach.

Specific signs that need prompt attention include severe stomach pain (especially if it radiates through to your back) with or without vomiting. The MHRA's Drug Safety Update in January 2026 confirmed acute pancreatitis as an infrequent but serious known risk with GLP-1 receptor agonist medicines; this is the symptom pattern to act on quickly. Signs of a serious allergic reaction (difficulty breathing, swelling of the face or throat, a rapid heartbeat) also require emergency help immediately.

Dehydration from repeated vomiting or diarrhoea is worth taking seriously too. If you cannot keep fluids down for an extended period, contact your prescriber or 111 rather than waiting for it to resolve on its own. For a fuller overview of the side-effect profile beyond week one, the complete Mounjaro side effects guide covers the longer picture, and if you want to understand the five most commonly reported Mounjaro side effects in more detail, that breakdown is worth reading alongside it. Any suspected side effect can be reported directly to the MHRA via the Yellow Card scheme.

What to consider before starting, and how a prescriber helps you weigh it up

Knowing that the first week is often the hardest can be genuinely reassuring. It is also the reason that clinical review before starting matters so much. A prescriber who knows your medical history can flag whether any pre-existing condition (a history of pancreatitis, certain gastrointestinal conditions or specific medicines) warrants extra caution or changes the risk-benefit picture. If you are approaching the end of your first week and want to know what typically happens next, reading about what side effects to expect in week three can help you plan ahead and spot any changes worth discussing with your prescriber.

Mounjaro is a prescription-only medicine; the NICE appraisal of tirzepatide sets out the clinical criteria under which it is recommended, and a prescriber works through that framework with you individually. At nume, that review is done by a GPhC-registered Independent Prescriber who reads your consultation the same day, a real clinician assessing your specific circumstances, not an automated system. Side effects, your starting dose and what to do if you're struggling are all part of that conversation. If you'd like to explore whether Mounjaro is suitable for you, our prescribers are the right starting point; you can begin with a free consultation.

For broader context on how tirzepatide works and what the treatment involves, the Mounjaro overview covers the full picture.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions